6533b826fe1ef96bd1284834
RESEARCH PRODUCT
Incidence and Clinical Impact of Recurrent Takotsubo Syndrome: Results From the GEIST Registry
Federico GuerraFabiana RomeoIbrahim El-battrawyEnrica MarianoIbrahim AkinAlessandro CapucciFrancesco RomeoChristian MöllerIngo EitelNatale Daniele BrunettiFrancesca GuastafierroIrene GianniniSalvatore NovoThomas StiermaierGiuseppina NovoHolger ThieleFrancesco Santorosubject
MalePediatricsmedicine.medical_specialtyrecurrenceCardiomyopathyVentricular Dysfunction RightShock Cardiogenic030204 cardiovascular system & hematology03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineTakotsubo CardiomyopathyGermanyThromboembolismMedicineHumans030212 general & internal medicineHospital MortalityRegistriesOriginal ResearchAgedProportional Hazards ModelsHeart FailureAged 80 and overTakotsubo syndromebusiness.industryIncidence (epidemiology)IncidenceStroke VolumeMiddle Agedmedicine.diseaseStrokeItalyBackground currentHeart failureHypertensionFemaleCardiology and Cardiovascular Medicinebusinessdescription
Background Current literature only reports variable information from single‐center studies on the recurrence rate, the complications, and the outcome of patients with Takotsubo syndrome ( TTS) experiencing recurrent TTS . Therefore, a detailed description of clinical characteristics, predictors, and the prognostic impact of patients with TTS and recurrences in a multicenter registry is needed. Methods and Results We analyzed 749 patients with TTS from 9 European centers being part of the international, multicenter GEIST (German Italian Stress Cardiomyopathy) Registry. Patients were divided into the recurrence group and the nonrecurrence group. The recurrence rate at a median follow‐up of 830 days (interquartile range, 118–1701 days) was 4%. Most recurrences were documented in the first 5 years after the index TTS episode. Up to 2 TTS recurrences were documented in 2 of 30 patients (6%). A variable ballooning pattern (n=6, 0.8%) with, in particular, involvement of the right ventricular occurred in 3 cases (0.4%) at the recurrence event. Except for the higher presence of arterial hypertension (86.7% versus 68.3%; P =0.03) in the recurrence group, no other baseline characteristics were different between groups. Observation of TTS complications during follow‐up, including stroke, thromboembolic events, in‐hospital death, and cardiogenic shock, revealed no significant differences between groups ( P >0.05), except the higher presence of pulmonary edema in the recurrence group versus the nonrecurrence group (13.3% versus 4.9%; P =0.04). Conclusions The incidence of TTS recurrence is estimated to be 4% in this multicenter TTS registry. A variable TTS pattern at recurrence is common in up to 20% of recurrence cases.
year | journal | country | edition | language |
---|---|---|---|---|
2019-05-01 | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |